Ordering molecular genetic tests: Clinician considerations and precautions
Wadia Journal of Women and Child Health · 09.03.2026 · 4 · 103-105
DOI: 10.25259/wjwch_30_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wadia Journal of Women and Child Health, online erschienen am 09.03.2026. Verfasst von Anupkumar Rawool und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Molecular genetic testing including targeted panels, whole-exome sequencing (WES), whole-genome sequencing, and somatic mutation analysis is increasingly becoming pivotal in clinical medicine. These tools aid in diagnosis, prognosis, treatment selection, and familial risk assessment. However, effective test utilization requires careful attention to analytical validity, clinical utility, informed consent, result interpretation, and ethical, legal, and societal implications. This review outlines clinician-oriented considerations and precautions across the pre-analytic, analytic, and post-analytic phases of testing, emphasizing multidisciplinary interpretation, patient-centered counseling, and the evolving governance landscape.
Zitieren
APA
Rawool, A., & Rawool, V. A. (2026). Ordering molecular genetic tests: Clinician considerations and precautions. Wadia Journal of Women and Child Health, 4, 103-105. https://doi.org/10.25259/wjwch_30_2025
Vancouver
Rawool A, Rawool VA. Ordering molecular genetic tests: Clinician considerations and precautions. Wadia Journal of Women and Child Health. 2026;4:103-105. doi:10.25259/wjwch_30_2025
BibTeX
@article{Rawool2026,
author = {Rawool, Anupkumar and Rawool, Vrushali Anupkumar},
title = {Ordering molecular genetic tests: Clinician considerations and precautions},
journal = {Wadia Journal of Women and Child Health},
year = {2026},
volume = {4},
pages = {103--105},
doi = {10.25259/wjwch_30_2025}
}
EUVIMED